Latest Equity Raise News

Minerals 260 Limited has launched a $200-$220 million public offer to fund the acquisition of the Bullabulling Gold Project in Western Australia, featuring a 2.3 million ounce JORC-compliant resource. The company seeks ASX re-admission following a significant change in scale of activities.

Goodman Group reports a robust 8% increase in 1H25 operating profit to $1.22 billion and launches a $4 billion equity placement to fund its ambitious data centre growth strategy across global metro hubs.

Goodman Group delivered a robust half-year performance with operating profit up 8.4% and statutory profit swinging to a $799.8 million gain. The industrial property giant also announced a $4 billion equity raise to fuel its expanding data centre and logistics developments.

Fletcher Building reported a challenging HY25 with a 7% revenue decline and a net loss of NZ$134 million, while executing a $700 million equity raise to strengthen its balance sheet and advancing significant cost reduction initiatives.

Adriatic Metals has completed a two-tranche institutional placement raising A$80 million to fast-track its Vares Processing Plant expansion and support production growth at Rupice Mine.

Select Harvests Limited delivered a standout FY24 with a record almond crop and a significant NPAT turnaround, underpinned by strategic cost management and a successful $80 million capital raise. The company signals continued growth and operational improvements heading into FY25.

Adriatic Metals has announced a A$80 million equity raising aimed at fast-tracking the expansion of its Vares Silver Operation in Bosnia and Herzegovina, supporting increased production capacity and strengthening its balance sheet.

Adriatic Metals has announced a two-tranche institutional placement to raise A$80 million, aiming to fast-track the expansion of its Vares Processing Plant and strengthen its balance sheet ahead of commercial production.

PYC Therapeutics has launched a A$145.8 million pro-rata accelerated non-renounceable entitlement offer to fund late-stage clinical trials across its pipeline targeting rare diseases with high unmet needs. The capital raise aims to extend the company’s cash runway beyond FY27, supporting four drug candidates through critical human safety and efficacy milestones.

PYC Therapeutics is set to raise up to $146 million through a pro-rata entitlement offer, aiming to accelerate its RNA-based drug candidates targeting major unmet medical needs. Major shareholder support and underwriting commitments underpin the capital raise.

Smart Parking Limited has reported robust H1 FY25 results, underpinned by a strategic acquisition of Peak Parking LP and a fully underwritten $45 million equity raise to fund its US expansion.

Smart Parking Limited is set to expand its global footprint by acquiring US-based Peak Parking LP for up to USD 36 million, backed by a fully underwritten equity raise and expanded debt facility. The deal promises significant EPS accretion and strategic growth opportunities in the lucrative US parking market.